Organization · Venture Capital
Modi Ventures
Modi Ventures is a venture capital firm based in the United States, focusing on early-stage investments at the intersection of technology and biology, particularly in the bioeconomy. The firm invests in disruptive AI and medical technology applications.
Overview
What Modi Ventures does
What Modi Ventures is
Modi Ventures is a venture capital firm based in the United States, focusing on early-stage investments at the intersection of technology and biology, particularly in the bioeconomy. The firm invests in disruptive AI and medical technology applications.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- April 9, 2026
Official channels
Find Modi Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Modi Ventures as a funder
Investment thesis
Modi Ventures invests at the intersection of technology and biology, focusing on the emerging bioeconomy through early-stage investments in technology platforms that positively impact health.
Focus narrative
Modi Ventures targets investments in funds and founders leading the bioeconomy, with a strong emphasis on areas such as artificial intelligence, microfluidics, multiomics, precision medicine, synthetic biology, gene editing, and living therapies. The organization is committed to supporting innovative solutions that enhance health outcomes.
Value beyond capital
Modi Ventures adds value to its portfolio companies through strategic partnerships, access to a robust network of co-investors, and expertise in both technology and healthcare. The team provides mentorship and guidance to entrepreneurs, leveraging their extensive backgrounds in AI, medical imaging, and cancer research.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Notable portfolio companies include: Proxima: Pioneering AI-driven drug discovery for proximity-based therapeutics. Exciva Therapeutics: Developing therapies for neuropsychiatric symptoms of dementia, including agitation and aggression in Alzheimer's disease. ProFound Therapeutics: Focused on discovering novel proteins encoded by the human genome to create breakthrough medicines. Kamau Therapeutics: A clinical-stage gene correction company developing therapies for serious diseases through targeted gene integration. March Biosciences: Developing advanced cell therapies for complex diseases like cancer and genetic disorders. Latus Bio: Working on curative medicines for neurological diseases using innovative AAV capsids. Komo Biosciences: Accelerating therapeutic development through high-efficiency integrases. UnNatural Products: Engineering synthetic molecules to create new drugs targeting traditionally undruggable targets.
Common questions
What to know about Modi Ventures
Upseed classifies Modi Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.